Kurtoglu Metin

CIK 00020002841 companyFREDERICK, MD

SEC Profile

Transactions

Companies

Filings

CIK

0002000284

Recent Transactions

43 trades

Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-06$16.83/sh−2,458→ 62,258 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-03$16.72/sh−2,417→ 64,716 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2025-01-02+47,400→ 47,400 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-02+16,100→ 67,133 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-12-10$1.41/sh+2,901→ 53,934 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-12-10−2,901→ 79,099 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-12-10$24.35/sh−2,901→ 51,033 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-12-09$25.26/sh−6,224→ 55,572 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-12-09$1.41/sh+10,763→ 61,796 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-12-09$25.83/sh−4,539→ 51,033 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-12-09−10,763→ 82,000 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-21$16.67/sh−32,789→ 51,033 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-21−32,789→ 92,763 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-21$1.41/sh+32,789→ 83,822 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-20−5,700→ 125,552 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-20$17.28/sh−5,600→ 51,133 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-20$1.41/sh+5,700→ 56,733 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-20$18.09/sh−100→ 51,033 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-19$1.41/sh+200→ 51,233 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-19$19.50/sh−200→ 51,033 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-19−200→ 131,252 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-18$18.19/sh−16,672→ 68,761 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-18−34,400→ 131,452 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-18$1.41/sh+34,400→ 85,433 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-18$18.58/sh−17,728→ 51,033 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-15$1.41/sh+22,068→ 73,101 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-15$17.20/sh−22,068→ 51,033 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-15−22,068→ 165,852 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-14$1.41/sh+25,900→ 76,933 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-11-14−25,900→ 187,920 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-14$16.33/sh−21,900→ 55,033 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-11-14$17.06/sh−4,000→ 51,033 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-04-08−427.645→ 0 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-04-08+14,254→ 14,254 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-04-08−6,414.682→ 0 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-04-08+213,820→ 213,820 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-04-08−427.646→ 0 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2024-04-08+14,254→ 14,254 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2024-01-02+1,965,000→ 1,965,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-01-02+1,531,000→ 1,531,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13+427.645→ 427.645 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13+6,414.682→ 6,414.682 total
Award
Cartesian Therapeutics, Inc.$RNAC
Stock Option (Right to Buy)
2023-11-13+427.645→ 427.645 total

Companies

Cartesian Therapeutics, Inc.
Chief Technology Officer
$RNAC

Recent Filings

Address

C/O CARTESIAN THERAPEUTICS, INC. 7495 NEW HORIZON WAY

FREDERICK, MD, 21703

View on SEC.gov